Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis
Clinical trial NCT00989807 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00989807
- Sponsor
- Gilead Sciences
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.